The reverse stop-signal model for CTLA4 function

Nature Reviews Immunology

Volumn 8, Issue 2, 2008, Pages 153-160

  Rudd, Christopher E ^a,b  

^a Department of Pathology   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INDOLEAMINE 2,3 DIOXYGENASE; SMALL INTERFERING RNA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN BINDING; ANTIGEN FUNCTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL ADHESION; CELL GROWTH; CELL INFILTRATION; CELL MIGRATION; CELL MOTILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENE LOCUS; IMMUNE RESPONSE; INFLAMMATION; LIPID RAFT; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOIMMUNITY; CELL MOVEMENT; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 38549089084     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2253     Document Type: Note

References (86)

1. Riley, J. L. & June, C. H. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 105, 13-21 (2005).
2. Chambers, C. A. et al. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol. Rev. 153, 27-46 (1996).
3. Abbas, A. K., Lohr, J., Knoechel, B. & Nagabhushanam, V. T cell tolerance and autoimmunity. Autoimmun. Rev. 3, 471-475 (2004).
4. Greenwald, R. J., Latchman, Y. E. & Sharpe, A. H. Negative co-receptors on lymphocytes. Curr. Opin. Immunol. 14, 391-396 (2002).
5. Rudd, C. E. & Schneider, H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nature Rev. Immunol. 3, 544-556 (2003).
6. Alegre, M. L., Frauwirth, K. A. & Thompson, C. B. T-cell regulation by CD28 and CTLA-4. Nature Rev. Immunol. 1, 220-228 (2001).
7. Zhang, X., Schwartz, J. C., Almo, S. C. & Nathenson, S. G. Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling. Proc. Natl Acad. Sci. USA 100, 2586-2591 (2003).
8. Stamper, C. C. et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410, 608-611 (2001).
9. van der Merwe, P. A., Bodian, D., Daenke, S., Linsley, P. & Davis, S. J. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185, 393-403 (1997).
10. Linsley, P. S. et al. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4, 535-543 (1996).
11. Egen, J. G. & Allison, J. P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16, 23-35 (2002).
12. Valk, E. et al. T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor. Immunity 25, 807-821 (2006).
13. Zhang, Y. & Allison, J. P. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Proc. Natl Acad. Sci. USA 94, 9273-9278 (1997).
14. Schneider, H. et al. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J. Immunol. 163, 1868-1879 (1999).
15. Shiratori, T. et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 6, 583-589 (1997).
16. Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988 (1995).
17. Tivol, E. A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
18. + T cells. Immunity 7, 885-895 (1997).
19. Gozalo-Sanmillan, S., McNally, J. M., Lin, M. Y., Chambers, C. A. & Berg, L. J. Cutting edge: two distinct mechanisms lead to impaired T cell homeostasis in Janus kinase 3- and CTLA-4-deficient mice. J. Immunol. 166, 727-730 (2001).
20. Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511 (2003).
21. Chen, Z., Stockton, J., Mathis, D. & Benoist, C. Modeling CTLA4-linked autoimmunity with RNA interference in mice. Proc. Natl Acad. Sci. USA 103, 16400-16405 (2006).
22. Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W. & Kopf, M. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128-1131 (1999).
23. Bachmann, M. F. et al. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 160, 95-100 (1998).
24. Sakaguchi, S. & Powrie, F. Emerging challenges in regulatory T cell function and biology. Science 317, 627-629 (2007).
25. + T regulatory cells. Nature Immunol. 4, 337-342 (2003).
26. + regulatory T cells. Nature Immunol. 4, 330-336 (2003).
27. + regulatory T cells abrogates their function in vivo. J. Immunol. 177, 4376-4383 (2006).
28. + T cells. J. Exp. Med. 188, 1849-1857 (1998).
29. Izcue, A., Coombes, J. L. & Powrie, F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212, 256-271 (2006).
30. Sullivan, T. J. et al. Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl Acad. Sci. USA 98, 2587-2592 (2001).
31. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100-4110 (2004).
32. Mellor, A. L. & Munn, D. H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Rev. Immunol. 4, 762-774 (2004).
33. Krummel, M. F. & Allison, J. P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540 (1996).
34. Walunas, T. L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413 (1994).
35. da Rocha Dias, S. & Rudd, C. E. CTLA-4 blockade of antigen-induced cell death. Blood 97, 1134-1137 (2001).
36. Yi, L. A., Hajialiasgar, S. & Chuang, E. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo. Int. Immunol. 16, 539-547 (2004).
37. Yin, L., Schneider, H. & Rudd, C. E. Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor. J. Leukoc. Bio. 73, 178-182 (2003).
38. Masteller, E. L., Chuang, E., Mullen, A. C., Reiner, S. L. & Thompson, C. B. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164, 5319-5327 (2000).
39. Engelhardt, J. J., Sullivan, T. J. & Allison, J. P. CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism. J. Immunol. 177, 1052-1061 (2006).
40. Tivol, E. A. et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158, 5091-5094 (1997).
41. -/- mice depends on a specific CD28 motif that is required for in vivo costimulation. Proc. Natl Acad. Sci. USA 104, 13756-13761 (2007).
42. Marengere, L. E. et al. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272, 1170-1173 (1996).
43. Parry, R. V. et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25, 9543-9553 (2005).
44. Pentcheva-Hoang, T., Egen, J. G., Wojnoonski, K. & Allison, J. P. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21, 401-413 (2004).
45. Lin, H. et al. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J. Exp. Med. 188, 199-204 (1998).
46. Hwang, K. W. et al. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice. J. Immunol. 173, 5415-5424 (2004).
47. Fallarino, F., Fields, P. E. & Gajewski, T. F. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J. Exp. Med. 188, 205-210 (1998).
48. Lee, K. M. et al. Molecular basis of T cell inactivation by CTLA-4. Science 282, 2263-2266 (1998).
49. Schneider, H. & Rudd, C. E. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition. Biochem. Biophys. Res. Commun. 269, 279-283 (2000).
50. Teft, W. A., Kirchhof, M. G. & Madrenas, J. A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 24, 65-97 (2006).
51. Chuang, E. et al. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13, 313-322 (2000).
52. + T cells from receptor/ligand-deficient mice. J. Immunol. 169, 3475-3479 (2002).
53. Martin, M., Schneider, H., Azouz, A. & Rudd, C. E. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J. Exp. Med. 194, 1675-1681 (2001).
54. Frearson, J. A. & Alexander, D. R. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells. J. Exp. Med. 187, 1417-1426 (1998).
55. Chambers, C. A. & Allison, J. P. Costimulatory regulation of T cell function. Curr. Opin. Cell Biol. 11, 203-210 (1999).
56. Li, D. et al. Cutting Edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J. Immunol. 173, 7135-7139 (2004).
57. Chiang, Y. J. et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216-220 (2000).
58. Bachmaier, K. et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211-216 (2000).
59. + T cells. J. Exp. Med. 204, 879-891 (2007).
60. Rudd, C. E., Martin, M. & Schneider, H. CTLA-4 negative signaling via lipid rafts: A new perspective. Sci. STKE 2002, PE18 (2002).
61. Chikuma, S., Imboden, J. B. & Bluestone, J. A. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 197, 129-135 (2003).
62. Viola, A., Schroeder, S., Sakakibara, Y. & Lanzavecchia, A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283, 680-682 (1999).
63. Yokosuka, T. et al. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nature Immunol. 6, 1253-1262 (2005).
64. Bunnell, S. C. et al. Persistence of cooperatively stabilized signaling clusters drives T-cell activation. Mol. Cell Biol. 26, 7155-7166 (2006).
65. Schneider, H., Smith, X., Liu, H., Bismuth, G. & Rudd, C. E. CTLA-4 expression disrupts ZAP-70 microcluster formation, T-cell/APC conjugation and calcium mobilization. Eur. J. Immunol. 38, 40-47 (2007).
66. Schneider, H., Prasad, K. V., Shoelson, S. E. & Rudd, C. E. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 181, 351-355 (1995).
67. Schneider, H., Valk, E., da Rocha Dias, S., Wei, B. & Rudd, C. E. CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function. Proc. Natl Acad. Sci. USA 102, 12861-12866 (2005).
68. Katagiri, K. et al. Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol. Cell Biol. 20, 1956-1969 (2000).
69. Dillon, T. J., Carey, K. D., Wetzel, S. A., Parker, D. C. & Stork, P. J. Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4. Mol. Cell Biol. 25, 4117-4128 (2005).
70. Wei, B., da Rocha Dias, S., Wang, H. & Rudd, C. E. CTL-associated antigen-4 ligation induces rapid T cell polarization that depends on phosphatidylinositol 3-kinase, Vav-1, Cdc42, and myosin light chain kinase. J. Immunol. 179, 400-408 (2007).
71. Schneider, H. et al. Reversal of the TCR stop signal by CTLA-4. Science 313, 1972-1975 (2006).
72. Dustin, M. L., Bromley, S. K., Kan, Z., Peterson, D. A. & Unanue, E. R. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc. Natl Acad. Sci. USA 94, 3909-3913 (1997).
73. + T cell priming by dendritic cells in intact lymph nodes. Nature Immunol. 4, 579-585 (2003).
74. Miller, M. J., Wei, S. H., Parker, I. & Cahalan, M. D. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296, 1869-1873 (2002).
75. Hugues, S. et al. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nature Immunol. 5, 1235-1242 (2004).
76. Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K. & Sharpe, A. H. CTLA-4 regulates induction of anergy in vivo. Immunity 14, 145-155 (2001).
77. + T cell anergy in vivo. J. Immunol. 167, 4936-4941 (2001).
78. Shakhar, G. et al. Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nature Immunol. 6, 707-714 (2005).
79. + T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance. J. Exp. Med. 201, 1815-1823 (2005).
80. Schwartz, R. H. A cell culture model for T lymphocyte clonal anergy. Science 248, 1349-1356 (1990).
81. Hogg, N., Laschinger, M., Giles, K. & McDowall, A. T-cell integrins: more than just sticking points. J. Cell Sci. 116, 4695-4705 (2003).
82. Dustin, M. L., Bivona, T. G. & Philips, M. R. Membranes as messengers in T cell adhesion signaling. Nature Immunol. 5, 363-372 (2004).
83. Downey, J., Smith, A., Schneider, H., Hogg, N. & Rudd, C. E. TcR/CD3 mediated stop-signal is decoupled in T-cells from CTLA-4 deficient mice. Immunol. Lett. 115, 70-72 (2008).
84. Zang, X. & Allison, J. P. The b7 family and cancer therapy: costimulation and coinhibition. Clin. Cancer Res. 13, 5271-5279 (2007).
85. Chikuma, S., Abbas, A. K. & Bluestone, J. A. B7-independent inhibition of T cells by CTLA-4. J. Immunol. 175, 177-181 (2005).
86. Dustin, M. L. Stop and go traffic to tune T cell responses. Immunity 21, 305-314 (2004).